Clinical Trial Update: Dosing Vancomycin in Patients on Sustained Low Efficiency Daily Hemodiafiltration (SLEDD-f)

View source ↗

Summary

A clinical trial update detailing vancomycin dosing for patients with acute kidney injury on sustained low-efficiency daily hemodiafiltration (SLEDD-f).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Acute Renal Failure | Status: COMPLETED